[Cytokines in immunopathogenesis of pulmonary tuberculosis]

Area of Science:

• Immunology
• Infectious Diseases
• Respiratory Medicine

Background:

• Pulmonary tuberculosis (TB) is a significant global health challenge.
• Immune dysregulation, particularly involving cytokine production, is implicated in TB pathogenesis.
• Understanding cytokine profiles in TB patients is crucial for assessing disease activity and treatment response.

Purpose of the Study:

• To investigate the production of key cytokines, including Interleukin-1 (IL-1), Interleukin-2 (IL-2), and gamma-interferon (IFN), in patients with pulmonary tuberculosis.
• To assess the impact of chemotherapy on these cytokine levels.

Main Methods:

• Quantification of cytokines (IL-1, IL-2, gamma-IFN, PNO) in 46 pulmonary TB patients.
• Utilized biological assays, radioimmunoassay, and enzyme immunoassay on blood lymphocyte supernatants.
• Monitored cytokine levels before and after 3-4 months of effective chemotherapy.

Main Results:

• Patients exhibited elevated levels of IL-1 and PNO.
• Reduced production of IL-2 and gamma-IFN was observed in stimulated blood mononuclear cells.
• Effective chemotherapy led to a decrease in IL-1 production.
• Chemotherapy resulted in increased production of IL-2 and gamma-IFN.

Conclusions:

• Pulmonary tuberculosis is associated with a specific cytokine profile characterized by high IL-1 and PNO, and low IL-2 and gamma-IFN.
• Effective chemotherapy can restore a more balanced cytokine production, suggesting immune system modulation during treatment.
• Cytokine profiling may serve as a biomarker for monitoring TB treatment efficacy.